Literature DB >> 7754531

Lower efficacy: interaction with an inhibitory receptor or partial agonism?

G E Rovati1, S Nicosia.   

Abstract

It is very common in practice to find that some concentration-response curves are 'bell shaped', and this phenomenon also applies to partial agonist curves. On the basis of these considerations, a mathematical model has been developed for the interaction of a ligand with two different receptors that mediate opposite effects (one stimulatory and one inhibitory), and is discussed in this article by Enrico Rovati and Simonetta Nicosia. This model can account for both an apparent reduction in efficacy and the curvature of the upper plateau of some concentration-response curves. Therefore, under certain conditions, an agonist that also interacts with an inhibitory receptor might be mistaken for a partial agonist, unless the concentration-response curves are performed over the widest possible range of concentrations.

Mesh:

Substances:

Year:  1994        PMID: 7754531     DOI: 10.1016/0165-6147(94)90073-6

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  9 in total

1.  Autocrine regulation of prolactin secretion by endothelins throughout the estrous cycle.

Authors:  Béla Kanyicska; Michael T Sellix; Marc E Freeman
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

2.  Superactive mutants of thromboxane prostanoid receptor: functional and computational analysis of an active form alternative to constitutively active mutants.

Authors:  Manuela Ambrosio; Francesca Fanelli; Silvia Brocchetti; Francesco Raimondi; Mario Mauri; G Enrico Rovati; Valérie Capra
Journal:  Cell Mol Life Sci       Date:  2010-04-11       Impact factor: 9.261

3.  The glycine residues G551 and G1349 within the ATP-binding cassette signature motifs play critical roles in the activation and inhibition of cystic fibrosis transmembrane conductance regulator channels by phloxine B.

Authors:  Patricia Melin; Caroline Norez; Isabelle Callebaut; Frédéric Becq
Journal:  J Membr Biol       Date:  2006-04-07       Impact factor: 1.843

4.  Differential adrenergic regulation of the gene expression of the beta-adrenoceptor subtypes beta1, beta2 and beta3 in brown adipocytes.

Authors:  T Bengtsson; B Cannon; J Nedergaard
Journal:  Biochem J       Date:  2000-05-01       Impact factor: 3.857

5.  Dualistic actions of cromakalim and new potent 2H-1,4-benzoxazine derivatives on the native skeletal muscle K ATP channel.

Authors:  Domenico Tricarico; Mariagrazia Barbieri; Laghezza Antonio; Paolo Tortorella; Fulvio Loiodice; Diana Conte Camerino
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

6.  Determinants in CaV1 channels that regulate the Ca2+ sensitivity of bound calmodulin.

Authors:  D Brent Halling; Dimitra K Georgiou; D J Black; Guojun Yang; Jennifer L Fallon; Florante A Quiocho; Steen E Pedersen; Susan L Hamilton
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

Review 7.  Adverse effects of opioid agonists and agonist-antagonists in anaesthesia.

Authors:  T A Bowdle
Journal:  Drug Saf       Date:  1998-09       Impact factor: 5.606

8.  A new benzoxazine compound blocks KATP channels in pancreatic beta cells: molecular basis for tissue selectivity in vitro and hypoglycaemic action in vivo.

Authors:  J-F Rolland; D Tricarico; A Laghezza; F Loiodice; V Tortorella; D Conte Camerino
Journal:  Br J Pharmacol       Date:  2006-10-23       Impact factor: 8.739

9.  Dose-response analysis in the joint action of two effectors. A new approach to simulation, identification and modelling of some basic interactions.

Authors:  Miguel Anxo Murado García; Miguel Ángel Prieto Lage
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.